LON:CLIN - Clinigen Group Stock Price, News & Analysis

Clinigen Group trades on the London Stock Exchange (LON) under the ticker symbol "CLIN."

Clinigen Group declared a dividend on Wednesday, February 27th. Stockholders of record on Thursday, March 21st will be paid a dividend of GBX 1.95 per share on Friday, April 12th. This represents a dividend yield of 0.21%. The ex-dividend date is Thursday, March 21st. The official announcement can be viewed at this link. View Clinigen Group's Dividend History.

Clinigen Group PLC (LON:CLIN) released its earnings results on Tuesday, February, 27th. The company reported $21.20 earnings per share for the quarter, beating analysts' consensus estimates of $20.30 by $0.90. The firm had revenue of $167.80 million for the quarter. View Clinigen Group's Earnings History.

Clinigen Group is scheduled to release their next quarterly earnings announcement on Thursday, September 19th 2019. View Earnings Estimates for Clinigen Group.

5 equities research analysts have issued twelve-month target prices for Clinigen Group's stock. Their predictions range from GBX 1,160 to GBX 1,640. On average, they expect Clinigen Group's stock price to reach GBX 1,371 in the next twelve months. This suggests a possible upside of 54.2% from the stock's current price. View Analyst Price Targets for Clinigen Group.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Clinigen Group in the last year. There are currently 4 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Clinigen Group.

Media coverage about CLIN stock has been trending somewhat positive this week, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Clinigen Group earned a media sentiment score of 0.9 on InfoTrie's scale. They also gave headlines about the company a news buzz of 1.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term. View News Stories for Clinigen Group.

Some companies that are related to Clinigen Group include Hikma Pharmaceuticals (HIK), Premier (PINC), Ascendis Pharma A/S (ASND), GW Pharmaceuticals PLC- (GWPH), Healthscope (HSO), Amedisys (AMED), LivaNova (LIVN), Healthequity (HQY), Repligen (RGEN), Neogen (NEOG), Spark Therapeutics (ONCE), Blueprint Medicines (BPMC), China Biologic Products (CBPO), Allogene Therapeutics (ALLO) and BTG (BTGGF).

Based on aggregate information from My MarketBeat watchlists, some companies that other Clinigen Group investors own include Comerica (CMA), Honda Motor (HMC), Advanced Accelerator Application (AAAP), First Hawaiian (FHB), Landec (LNDC), NII (NIHD), Albemarle (ALB), RTI International Metals (RTI), NetApp (NTAP) and StatPro Group (SOG).

Shares of CLIN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

One share of CLIN stock can currently be purchased for approximately GBX 889.

Clinigen Group has a market capitalization of £1.18 billion and generates £422.30 million in revenue each year. Clinigen Group employs 849 workers across the globe.View Additional Information About Clinigen Group.

The official website for Clinigen Group is http://www.clinigengroup.com/.

Clinigen Group's mailing address is Pitcairn House Crown Square, First Avenue, STAFFORDSHIRE, DE14 2WW, United Kingdom. The company can be reached via phone at +44-1283-495010.